Potential anticancer agents. VI. 5-Substituted pyrimidine-6-carboxaldehydes.
D000447:Aldehydes / Q000138:chemical synthesis / Q000378:metabolism / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000378:metabolism / Q000627:therapeutic use; D002247:Carbon Isotopes; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D055598:Chemical Phenomena; D002621:Chemistry; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005472:Fluorouracil / Q000627:therapeutic use; D005561:Formates / Q000037:antagonists & inhibitors; D051379:Mice; D009963:Orotic Acid / Q000037:antagonists & inhibitors; D010649:Phenylalanine / Q000037:antagonists & inhibitors; D014176:Protein Biosynthesis; D011743:Pyrimidines / Q000138:chemical synthesis / Q000378:metabolism / Q000627:therapeutic use; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013936:Thymidine / Q000037:antagonists & inhibitors; D014316:Tritium
D000447:Aldehydes; D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D005561:Formates; D011743:Pyrimidines; D012334:RNA, Neoplasm; D014316:Tritium; D010649:Phenylalanine; D009963:Orotic Acid; D005472:Fluorouracil; D013936:Thymidine